Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF

Loncar Cancer Immunotherapy ETF (CNCR): $13.88

0.39 (-2.73%)

POWR Rating

Component Grades

Buy & Hold

C

Peer

D

Add CNCR to Watchlist
Sign Up

Category: Health & Biotech ETFs

Category

C

Ranked

#32 of 42

in category

CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market

Current price $13.88 52-week high $17.96
Prev. close $14.27 52-week low $9.22
Day low $13.88 Volume 6,500
Day high $14.14 Avg. volume 23,790
50-day MA $14.87 Dividend yield N/A
200-day MA $13.46

CNCR Stock Price Chart Interactive Chart >


Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio


The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.

CNCR ETF Info

Issuer Range ETFs
Expense Ratio 0.79%
Underlying Index Range Cancer Therapeutics Index
Asset Class Equity
Sector Health & Biotech ETFs
Assets Under Management (AUM) 16.38M
Net Asset Value (NAV) $13.88
Options? Yes
Total Holdings N/A

CNCR Top Holdings

Symbol Company % of Total

CNCR Price Returns

1-mo -8.68%
3-mo -12.76%
6-mo 11.22%
1-year 1.98%
3-year -51.00%
5-year -28.08%
YTD 3.04%
2023 -1.89%
2022 -42.31%
2021 -19.24%
2020 36.53%
2019 24.22%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!